![These highlights do not include all the information needed to use Timolol GFS safely and effectively. See full prescribing information for Timolol GFS.Timolol GFS (timolol maleate ophthalmic gel forming solution) 0.25% and These highlights do not include all the information needed to use Timolol GFS safely and effectively. See full prescribing information for Timolol GFS.Timolol GFS (timolol maleate ophthalmic gel forming solution) 0.25% and](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=carton-5.jpg&id=584396)
These highlights do not include all the information needed to use Timolol GFS safely and effectively. See full prescribing information for Timolol GFS.Timolol GFS (timolol maleate ophthalmic gel forming solution) 0.25% and
![Figure 4 from RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds | Semantic Scholar Figure 4 from RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/19d18b551749aea8e37f4e3032ca2f1f50bcb710/7-Figure4-1.png)
Figure 4 from RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds | Semantic Scholar
![Frontiers | Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma Frontiers | Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma](https://www.frontiersin.org/files/Articles/258443/fonc-07-00137-HTML/image_m/fonc-07-00137-g002.jpg)